Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Immunother. 2013 Feb;36(2):152–157. doi: 10.1097/CJI.0b013e3182811ae4

Table 4.

Multivariate stratified Cox model for Overall Survival.

Covariate Hazard Ratio 95% C.I. for Hazard Ratio p-value
Treg-fold change (1 unit increase) 4.56 (0.96, 21.73) 0.057
Overall Tumor Path Effects 0.485
    Recurrent Grade IV vs. newly dx Grade IV 2.08 (0.53, 8.16) 0.293
    Recurrent Grade IV vs Grade III 3.57 (0.26, 48.00) 0.338
    Grade IV vs. Grade III 1.71 (0.16, 18.92) 0.661

*Stratification is on trials. Covariates included are tumor pathology and Treg cell fold change.